Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 6.15
-0.05 (-0.81%)
At close: Sep 16, 2026
Labiana Health Market Cap
Labiana Health has a market cap or net worth of €51.45 million as of September 16, 2026. Its market cap has increased by 82.70% in one year.
Market Cap
51.45M
Enterprise Value
81.24M
Revenue
76.44M
Ranking
n/a
PE Ratio
16.97
Stock Price
€6.15
ChartMarket Cap Chart
Since June 24, 2022, Labiana Health's market cap has increased from 33.22M to 51.45M, an increase of 54.90%. That is a compound annual growth rate of 10.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 51.45M | 51.97% |
| Dec 31, 2025 | 33.86M | 62.46% |
| Dec 31, 2024 | 20.84M | 134.14% |
| Dec 29, 2023 | 8.90M | -63.32% |
| Dec 30, 2022 | 24.26M | -26.96% |
| Jun 24, 2022 | 33.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.86B |
| Laboratorios Farmaceuticos Rovi | 2.93B |
| Almirall | 2.22B |
| Faes Farma | 1.39B |
| Oryzon Genomics | 228.51M |
| Prim, S.A. | 217.71M |
| Laboratorio Reig Jofre | 215.74M |
| Atrys Health | 204.95M |